SQ109
| Names | |
|---|---|
| Preferred IUPAC name
N1-(Adamantan-2-yl)-N2-[(2E)-3,7-dimethylocta-2,6-dien-1-yl]ethane-1,2-diamine | |
| Identifiers | |
3D model (JSmol) |
|
PubChem CID |
|
| UNII | |
CompTox Dashboard (EPA) |
|
| |
| Properties | |
| C22H38N2 | |
| Molar mass | 330.560 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references | |
SQ109 is a drug undergoing development for treatment of tuberculosis.